Team:Freiburg bioware/Project/fokmonomer

   FREiGEM  

  Home   The Team </a> <ul> Overview</a></li> Portraits</a></li> </ul> </li> <span class="l"> <span class="t">The Project </a> <ul> Summary</a> </li> Subprojects</a></li> Highlights</a></li> </ul> </li> <span class="l"> <span class="t">Human Practice </a> <ul> Ethics</a> </li> <li><a href="http://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Safety">Safety</a></li> </ul> </li> <li><a href="#"> <span class="r"> Notebook </a></li> <li><a href="http://2009.igem.org/Team:Freiburg_bioware/cloning1"><span class="l"> <span class="t">Parts </a> <ul> <li><a href="http://2009.igem.org/Team:Freiburg_bioware/cloning1">Basic Parts</a></li> <li><a href="http://2009.igem.org/Team:Freiburg_bioware/cloning">Composite Parts</a></li> </ul> </li> <li><a href="http://2009.igem.org/Team:Freiburg_bioware/Collaboration"><span class="l"> <span class="t">Collaboration </a></li> <li><a href="http://2009.igem.org/Team:Freiburg_bioware/Modeling"><span class="l"> <span class="t">Modeling </a> </li> </ul> <h2 class="art-PostHeaderIcon-wrapper"> <img style="width: 28px; height: 25px;" alt="" src="http://2009.igem.org/wiki/images/2/2a/Freiburg09_Post_tanne_2.png" /> Fok Monomer <p class="MsoNormal" style="text-align: justify;"><b style=""> Introduction<o:p></o:p> </b> <p class="MsoNormal" style="text-align: justify;"><o:p> </o:p> <p style="text-align: justify;"><span style="" lang="EN-GB">In order to create a universal restriction enzyme, we followed several ideas and models. The first and most promising idea we had was to create a monomeric restriction enzyme as it represents the optimal and easiest model for a universal restriction enzyme<o:p></o:p> <p class="MsoNormal" style="text-align: justify;"> <span style="" lang="EN-GB"><o:p><span style="text-decoration: none;"> </o:p> <span style="" lang="EN-GB">If we are able to employ a monomeric enzyme, this protein would have a couple of advantages: Most importantly we would no longer need two separate oligonucleotides to achieve specific binding and cleavage of the target DNA. Also, only one protein has to be purified – thus saving time and money. A scientific advantage is the option to optimize the monomer by phage display. Using this technology, we would have the chance to create a thermostable, specific, universal restriction enzyme whose DNA binding specificity is simply created by a single oligonucleotide.<o:p></o:p> <p class="MsoNormal" style="text-align: justify;"> <span style="" lang="EN-GB"><o:p><span style="text-decoration: none;"> </o:p> <span style="" lang="EN-GB">Our goal was first, to create a Fok-monomer that is able to cut DNA without a primary dimerization step, and second, to show that our heterodimeric interface design works properly. To reach this, we had to clone all the required parts one after another, resulting in a huge fusion protein.<o:p>

</o:p> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB"><o:p></b>

</o:p> <span style="" lang="EN-GB">Results<o:p></o:p> </b> <p class="MsoNormal" style="text-align: justify;"> <span style="" lang="EN-GB">3D modeling and design goals<o:p></o:p>  </b> <p class="MsoNormal" style="text-align: justify;"> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB"><o:p></o:p> <span style="font-size: 10pt;" lang="EN-GB"> <span style="" lang="EN-US">The necessary parts in the model of a monomeric restriction enzyme are: Tag-binding protein (lipocalin) - Fok heterodimer1 - linker - Fok heterodimer2 (Fig. 1). <o:p></o:p> <p class="MsoNormal" style="text-align: justify;"><span style="font-size: 10pt;" lang="EN-US"><o:p> </o:p> <span style="font-size: 10pt;" lang="EN-US"><o:p> </o:p> <span style="font-size: 10pt;" lang="EN-US"><o:p></o:p> <span style="font-size: 9pt;" lang="EN-US">Tab. 1: List of parts usable for Fok Monomer<o:p></o:p> <p class="MsoNormal" style="text-align: justify;"><span style="font-size: 9pt;" lang="EN-US"><o:p></o:p> <span style="" lang="EN-US">In order to purify this fusion protein, we employed an N-terminal tag. The binding protein (a lipocalin-derived binding protein referred to as anticalin in analogy to antibodies) mediates between the FokI protein and the tagged oligonucleotide <span style="" lang="EN-GB">. Both parts of the Fok heterodimers are associated with a long flexible linker allowing them to establish the cutting site conformation. This artificial restriction nuclease domain is the functional part of the monomer and catalyzes the DNA cleavage.<o:p></o:p> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB"><o:p></o:p>Before we started in the wet lab, we thoroughly planned all the individual steps. To figure out the best way to create the Fok monomer, we first designed it in silico.<o:p></o:p></i> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB"> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB">The model (Fig. 2) shows that we have to use a linker which is about 70 Angstrom in length to span the required distance between the two Fok parts. Therefore, we decided to order two complementary oligonucleotides encoding a 36 amino acid long glycine-serine linker.<o:p></o:p> <p class="MsoNormal" style="text-align: justify;"><span style="display:block; width:100%; overflow:scroll;" lang="EN-GB"><o:p> </o:p> 5'-CTAGATGGCCGGCGGTTCTGGTGGTGGTTCTGGCGGTGGTTCTGGAGGTAGTTCTGGCGGTGGATCTGGAGGCGGTTCTGGGTCAGGATCTGGTG<b style=""> GA </b>GGTTCTGGCTCTGGGAATCAGA-3' 3'-TACCGGCCGCCAAGACCACCACCAAGACCGCCACCAAGACCTCCATCAAGACCGCCACCTAGACCTCCGCCAAGACCCAGTCCTAGACCAC<b style=""> TA </b>CCAAGACCGAGACCCTTAGTCTGGCC-5<o:p></o:p> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB"><o:p></o:p><span style="text-decoration: underline;"> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB"><span style="text-decoration: underline;">Cloning <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB">However, at this stage the first problem appeared.<o:p></o:p> These are the oligonucleotides, each 120 nt long, which we ordered from Mr.Gene. Unfortunately, we made a mistake when ordering the complementary oligonucleotide. Accidentally we introduced two mismatches (compare colored bases in the sequence). But somehow we managed to dimerize the two oligonucleotides.<o:p></o:p> After dimerization in the thermocycler and cloning into a pMA (BBa_K243031) vector (XbaI/AgeI) some mutations appeared in the 36GSLinker gene caused by the mismatches. As there was no frame shift we decided to carry on. <o:p></o:p>

First, we picked the parts we were going to use. We decided to use one we already completed in our earlier experiments: His – FluA – <st1:place w:st="on"><st1:City w:st="on">Split</st1:City></st1:place> - Foki (BBa_K243010) had all the functions we needed. These are (i) a purification tag, (ii) a Fok domain and (iii) the anticalin that binds the tagged oligonucleotide (Fig. 1). Cloning the linker (no part) behind these parts was the next step. We followed the assembly standard 25 and opened the vector with AgeI and PstI and cut the inserted with NgoMIV and PstI.<o:p></o:p> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB"><o:p> </o:p>

However, we ran into some more problems. After cloning Foka (BBa_K243000) after the other parts, again assembly standard 25, we performed test restriction digests cutting out the insert to confirm its size. These digests showed that the plasmid became even smaller as it would be without an insertion (pEX: ~ 4,5kbp and after test digestion ~ 2,2kbp). The insert should have a size of about 1.9 kbp but was found to be only about 900 bp (Fig. 3). The sequencing did not work either.<o:p>

</o:p> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB">Most likely, the active Fok did cut the plasmid and promoted deletion of the Fok gene, which gave such mutated cells a significant growth advantage. After we encountered these problems, we decided to order the 36GS-linker (GSAT Linker: BBa_K243029) as gene synthesis.<o:p></o:p> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB"><o:p> </o:p>5&acute;-GAGCTCGAATTCGCGGCCGCTTCTAGATGGCCGGCGGTGGTTCTGCCGGT<o:p></o:p>GGCTCCGGTTCTGGCTCCAGCGGTGGCAGCTCTGGTGCGTCCGGCACGGG<o:p></o:p>

TACTGCGGGTGGCACTGGCAGCGGTTCCGGTACTGGCTCTGGCACCGGTA<o:p></o:p>ATACTAGTAGCGGCCGCTGCAGGGTACC-3&acute;<o:p></o:p> <p class="MsoNormal" style="text-align: justify;"><span style="" lang="EN-GB"><o:p></o:p>This time the order was well planned but, unfortunately, it took over 4 weeks for the synthesis and delivery, and the genes arrived too late. Once again we have to make all the cloning steps. As of mid October 2009, the project is still in progress.<o:p></o:p>

contact: <a href="mailto:freigem09@googlemail.com">freigem09@googlemail.com</a>